How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

946 results for

Anxiety Non-pharmacologic Management

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. Orthostatic Hypotension Management

(preferred alternatives: ACEI/ARB, or adjust or split dose); antiparkinson’s, antipsychotics, barbiturates, ethanol, insulin, MAOIs monoamine oxidase inhibitors, nitrates, opiates, phosphodiesterase inhibitors, sedatives, TCAs (alternative: SSRI), & trazodone ? Consider stopping, reducing or changing the offending drug/dose c) NON-PHARMACOLOGICAL MANAGEMENT 2,5,7,11,13,14 ? Get Up Gradually: avoid getting up or moving too quickly (e.g. count to 15 when going from lying to sitting, & sitting to standing (...) ) PHARMACOLOGIC MANAGEMENT OPTIONS 1, 2,3,5,7,10,11,12,14,15,17,19 When non-pharmacological measures are inadequate, pharmacologic agents may be used in addition to nonpharmacological therapies, especially in nOH. Note: [Meds treating OH can also cause supine HTN] Fludrocortisone FLORINEF (see Table 2) – most commonly used drug for OH. Midodrine AMATINE (see Table 2) – less commonly used, but noted in literature. Beta blockers (non-selective): limited role, despite negative chronotrophy & inotropy. Caffeine

2014 RxFiles

102. Core Competencies for Management of Labour

of labour.Core Nursing Practice Competencies: Managing Labour 4 Perinatal Services BC Copyright © 2011 - PSBC Managing Labour in an Institutional Setting if the Primary Maternal Care Provider is Absent KNOWLEDGE of: SKILL in: JUDGMENT or reasoning in: ATTITUDE by: 2. Organization, Coordination and Provision of Care • Methods used to promote labour progress and comfort • Physical and psychological needs during labour and birth • Non-pharmacologic comfort techniques and pharmacologic pain relief options (...) • Anticipated length of each phase and stage of labour • Ongoing maternal assessments • Maternal physical and psychosocial needs ¦ Emotional and psychosocial support ¦ Oxygenation ¦ Nutrition/HydrationCore Nursing Practice Competencies: Managing Labour 10 Perinatal Services BC Copyright © 2011 - PSBC ¦ Rest, activity, and freedom of movement during labour ¦ Non pharmacologic and pharmacological comfort measures ? Incorporating the woman’s and family choices ? Indications and contraindications for pain

2014 British Columbia Perinatal Health Program

103. Management of Substance Use Disorder

for the update to this CPG. D. Highlighted Features of this Clinical Practice Guideline The 2015 edition of the VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders is the second update to the original CPG. It provides practice recommendations for the care of populations with SUD with any level of severity. While screening for and addressing co-occurring mental disorders is considered good clinical practice, specific guidance on management of co-occurring mental health conditions (...) Management of Substance Use Disorder VA/DoD CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF SUBSTANCE USE DISORDERS Department of Veterans Affairs Department of Defense QUALIFYING STATEMENTS The Department of Veterans Affairs and the Department of Defense guidelines are based upon the best information available at the time of publication. They are designed to provide information and assist decision making. They are not intended to define a standard of care and should not be construed as one

2015 VA/DoD Clinical Practice Guidelines

104. Supraventricular Tachycardia: Guideline For the Management of Adult Patients With

Supraventricular Tachycardia: Guideline For the Management of Adult Patients With CLINICAL PRACTICE GUIDELINE 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society Writing Committee Members* Richard L. Page, MD, FACC, FAHA, FHRS, Chair José A. Joglar, MD, FACC, FAHA, FHRS, Vice Chair Mary A. Caldwell, RN (...) or Documented SVT e34 2.3.1. Clinical Presentation and Differential Diagnosis on the Basis of Symptoms e34 2.3.2. Evaluation of the ECG .. e36 2.4. Principles of Medical Therapy ... e40 2.4.1. Acute Treatment: Recommendations e41 2.4.2. Ongoing Management: Recommendations e43 2.5. Basic Principles of Electrophysiological Study, Mapping, and Ablation.. e45 2.5.1. Mapping With Multiple and Roving Electrodes e45 2.5.2. Tools to Facilitate Ablation, Including 3-Dimensional Electroanatomic Mapping.. e45 2.5.3

2015 American College of Cardiology

105. HTA of Chronic Disease Self-Management

HTA of Chronic Disease Self-Management DRAFT - Health technology assessment of chronic disease self management support interventions – Phase I Health Information and Quality Authority Health technology assessment of chronic disease self-management support interventions 16 December 2015 Safer Better Care Health technology assessment of chronic disease self-management support interventions Health Information and Quality Authority i Health technology assessment of chronic disease self-management (...) services. Health technology assessment of chronic disease self-management support interventions Health Information and Quality Authority iii Health technology assessment of chronic disease self-management support interventions Health Information and Quality Authority iv Foreword An estimated 30% of adults living in Ireland are affected by chronic diseases. These are long-term conditions that are managed rather than cured, and which are responsible for a significant proportion of premature deaths

2015 Health Information and Quality Authority

106. Acute Pain Management: Scientific Evidence

Acute Pain Management: Scientific Evidence ACUTE PAIN MANAGEMENT: SCIENTIFIC EVIDENCE Fourth Edition 2015 Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine Edited by: Stephan A Schug Greta M Palmer David A Scott Richard Halliwell Jane T rinca© Australian and New Zealand College of Anaesthetists 2015 ISBN Print: 978-0-9873236-7-5 Online: 978-0-9873236-6-8 This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part may be reproduced (...) and Faculty of Pain Medicine (2015), Acute Pain Management: Scientific Evidence (4th edition), ANZCA & FPM, Melbourne. Copyright information for Tables 10.1 and 10.2 The material presented in Table 10.1 and Table 10.2 of this document has been reproduced with permission from Prescribing Medicines in Pregnancy, 2015, Therapeutic Goods Administration. It does not purport to be the official or authorised version. © Commonwealth of Australia 2015 This work is copyright. You may download, display, print

2015 Clinical Practice Guidelines Portal

107. Community management of opioid overdose

or group level. Psychosocial interventions range from structured, professionally-administered psychological interventions (such as cognitive behaviour therapy or insight-oriented psychotherapy) to non-professional psychological and social interventions (such as self-help groups and non-pharmacological interventions from traditional healers, accommodation, financial support, legal support, employment assistance, information and outreach). vi Community management of opioid overdose rebound toxicity (...) reviews, presented the findings to the GDG, wrote the first draft of the guidance and assisted with preparation of the final guideline document. Anna Williams and Rebecca McDonald assisted with the preparation of background documentation. WHO staff: Tomas Allen (WHO library) assisted with the development and conduct of the literature search. WHO interns: Agata Boldys (Management of Substance Abuse unit) assisted with the organization of the meeting and the preparation of background documents. Sally

2015 World Health Organisation Guidelines

108. Management of chronic pain

resource and support to manage their patients properly and have facilities for accessing appropriate specialist services when required. Within Scotland there is evidence of wide variation in clinical practice service and resource provision, with a general lack of knowledge about chronic pain and the management options that are available. 7 A wide range of both pharmacological and non-pharmacological management strategies are available for chronic pain. The challenge is to understand the extensive (...) weeks but with an increased risk of gastrointestinal bleeding. 69 C Paracetamol (1,000-4,000 mg/day) should be considered alone or in combination with NSAIDs in the management of pain in patients with hip or knee osteoarthritis in addition to non-pharmacological treatments. 5.2.3 NEFOPAM The evidence identified on the use of nefopam for chronic pain relief is not sufficient to support a recommendation. 70 5.2.4 TOPICAL NSAIDS T opical NSAIDs were significantly more effective than placebo

2013 SIGN

109. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada

Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada A Publication of the Professional Sections of the Canadian Diabetes Association Une publication des sections professionnelles de l'Association canadienne du diab ete CONTENTS: April 2013 - Volume 37 - Supplement 1 S1 Introduction S4 Methods S8 De?nition, Classi?cation and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome S12 Screening for Type 1 and Type 2 Diabetes (...) S16 Reducing the Risk of Developing Diabetes Management S20 Organization of Diabetes Care S26 Self-Management Education S31 Targets for Glycemic Control S35 Monitoring Glycemic Control S40 Physical Activity and Diabetes S45 NutritionTherapy S56 Pharmacotherapy inType 1 Diabetes S61 Pharmacologic Management of Type 2 Diabetes S69 Hypoglycemia S72 Hyperglycemic Emergencies in Adults S77 In-hospital Management of Diabetes S82 Weight Management in Diabetes S87 Diabetes and Mental Health S93 In?uenza

2013 CPG Infobase

110. Management of schizophrenia

Management of schizophrenia SIGN 131 • Management of schizophrenia A national clinical guideline March 2013 Evidence Help us to improve SIGN guidelines - click here to complete our survey KEY TO EVIDENCE STATEMENTS AND GRADES OF RECOMMENDATIONS LEVELS OF EVIDENCE 1 ++ High quality meta-analyses, systematic reviews of RCTs, or RCTs with a very low risk of bias 1 + Well conducted meta-analyses, systematic reviews, or RCTs with a low risk of bias 1 - Meta-analyses, systematic reviews, or RCTs (...) ; or Extrapolated evidence from studies rated as 2 + GOOD PRACTICE POINTS ? Recommended best practice based on the clinical experience of the guideline development group NHS Evidence has accredited the process used by Scottish Intercollegiate Guidelines Network to produce guidelines. Accreditation is valid for three years from 2009 and is applicable to guidance produced using the processes described in SIGN 50: a guideline developer’s handbook, 2008 edition (www.sign.ac.uk/guidelines/fulltext/50/index. html

2013 SIGN

111. Non-pharmacological interventions during pregnancy to reduce symptoms of anxiety: a systematic review of quantitative and qualitative evidence

Non-pharmacological interventions during pregnancy to reduce symptoms of anxiety: a systematic review of quantitative and qualitative evidence Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne (...) will be used to account for anticipated heterogeneity. ">Effect models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one experimental group, we will correct the total number of control animals in the meta-analysis by dividing the number of animals in the control group by the number of treatment groups served. Where

2015 PROSPERO

112. Systematic review and meta-analysis of pharmacological and non-pharmacological interventions for depression and anxiety in persons with rheumatoid arthritis

Systematic review and meta-analysis of pharmacological and non-pharmacological interventions for depression and anxiety in persons with rheumatoid arthritis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith (...) of animal studies, a random effects model will be used to account for anticipated heterogeneity. ">Effect models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one experimental group, we will correct the total number of control animals in the meta-analysis by dividing the number of animals in the control group

2015 PROSPERO

113. Systematic review and meta-analysis of pharmacological and non-pharmacological interventions for depression and anxiety in persons with multiple sclerosis

Systematic review and meta-analysis of pharmacological and non-pharmacological interventions for depression and anxiety in persons with multiple sclerosis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith (...) of animal studies, a random effects model will be used to account for anticipated heterogeneity. ">Effect models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one experimental group, we will correct the total number of control animals in the meta-analysis by dividing the number of animals in the control group

2015 PROSPERO

114. Systematic review and meta-analysis of pharmacological and non-pharmacological interventions for depression and anxiety in persons with inflammatory bowel disease

Systematic review and meta-analysis of pharmacological and non-pharmacological interventions for depression and anxiety in persons with inflammatory bowel disease Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr (...) of animal studies, a random effects model will be used to account for anticipated heterogeneity. ">Effect models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one experimental group, we will correct the total number of control animals in the meta-analysis by dividing the number of animals in the control group

2015 PROSPERO

115. Prevalence and management of chronic breathlessness in COPD in a tertiary care center. (Full text)

Prevalence and management of chronic breathlessness in COPD in a tertiary care center. Breathlessness is the prominent symptom of chronic obstructive pulmonary disease (COPD). Despite optimal therapeutic management including pharmacological and non-pharmacological interventions, many COPD patients exhibit significant breathlessness. Chronic breathlessness is defined as breathlessness that persists despite optimal treatment of the underlying disease. Because of the major disability related (...) to chronic breathlessness, symptomatic treatments including opioids have been recommended by several authors. The prevalence of chronic breathlessness in COPD and its management in routine clinical practice have been poorly investigated. Our aim was to examine prevalence, associated characteristics and management of chronic breathlessness in patients with COPD recruited in a real-life tertiary hospital-based cohort.A prospective study was conducted among 120 consecutive COPD patients recruited, in stable

2019 BMC pulmonary medicine PubMed abstract

116. Pain Management For Pediatric Patients in the Emergency Department: Guidelines

Guidelines and Recommendations 3. National Institute for Health and Clinical Excellence. Sickle cell acute painful episode: management of an acute painful sickle cell episode in hospital [Internet]. London: The Institute; 2012. [cited 2013 Nov 28]. (NICE clinical guideline 143). Available from: http://www.nice.org.uk/nicemedia/live/13772/59765/59765.pdf 4. Pillai Riddell RR, Racine NM, Turcotte K, Uman LS, Horton RE, Din OL, et al. Non- pharmacological management of infant and young child procedural pain (...) Pain Management For Pediatric Patients in the Emergency Department: Guidelines TITLE: Pain Management For Pediatric Patients in the Emergency Department: Guidelines DATE: 29 November 2013 RESEARCH QUESTION What are the evidence-based guidelines regarding pain management for pediatric patients in the emergency department? KEY MESSAGE Two systematic reviews and three evidence-based guidelines were identified regarding pain management for pediatric patients in the emergency department. METHODS

2013 Canadian Agency for Drugs and Technologies in Health - Rapid Review

117. Management of Arterial Hypertension

Management of Arterial Hypertension ESH AND ESC GUIDELINES 2013 ESH/ESC Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Authors/Task Force Members: Giuseppe Mancia (Chairperson) (Italy) * , Robert Fagard (Chairperson) (Belgium) * , Krzysztof Narkiewicz (Section co-ordinator) (Poland), Josep Redon (Section co-ordinator) (Spain), Alberto (...) . . . . . . . . . . . . . . . . . . . . .2206 6.16 Hypertensive emergencies and urgencies . . . . . . . . . .2206 6.17 Perioperative management of hypertension . . . . . . . .2206 6.18 Renovascular hypertension . . . . . . . . . . . . . . . . . . .2206 6.19 Primary aldosteronism . . . . . . . . . . . . . . . . . . . . . .2206 7 Treatment of associated risk factors . . . . . . . . . . . . . . . . . .2207 7.1 Lipid-lowering agents . . . . . . . . . . . . . . . . . . . . . . . .2207 7.2 Antiplatelet therapy

2013 European Society of Cardiology

118. Behavioural and psychological symptoms of dementia: GPs’ perspective on management

a significant impact on the caregivers; both emotionally and physically. One of the key problems in this area is that the evidence for the management of BPSDs is limited. Although non-pharmacological interventions such as personalised music therapy are recommended as first line treatment, these interventions are not taken up (Marston et al, 2014). On the other hand, commonly used treatments such as antipsychotics have limited evidence and significant side effects. So do GPs need more support in managing (...) to access relevant advice and support from other health professionals Time-intensive: managing BPSDs is overwhelming for GPs who are under tight time constraints. Justification of antipsychotic prescribing Antipsychotics to facilitate coping: GPs see the use of antipsychotic medication as a way to improve quality of life, which outweigh the risk factors Barriers to implementation of non-pharmacological strategies: Pressure from nursing home staff to prescribe medication, understaffed nursing homes, lack

2018 The Mental Elf

119. Pre-conception - advice and management

outcomes from the Academy of Nutrition and Dietetics [ ]; an AAFP position statement on Preconception care [ ]; a UKTIS monograph on Obesity in pregnancy [ ]; and expert opinion in review articles [ ; ]. Weight loss The recommendation to advise women to lose weight if obese, and the target weight loss suggested is based on the NICE public health guidance: Weight management before, during and after pregnancy [ ]. The recommendation to offer a weight loss support programme is based on expert opinion (...) in the NICE public health guidance: Weight management before, during and after pregnancy [ ] and a report on obesity, reproduction and pregnancy outcomes from the Academy of Nutrition and Dietetics [ ]. Although a Cochrane systematic review found no randomised controlled trials assessing the effect of preconception interventions on pregnancy outcomes for overweight or obese women [ ], a NIHR report: Better beginnings, improving health for pregnancy was of the opinion that women in these groups could

2017 NICE Clinical Knowledge Summaries

120. Mindfulness Training for Chronic Pain Management: A Review of the Clinical Evidence and Guidelines

and short durations. There were no adverse events reported in any of the trials included in this review. Chou et al (2007) 14 conducted a systematic review of RCTs and existing systematic reviews to evaluate the use of non-pharmacologic therapies in the treatment of acute and chronic low back pain. The non-pharmacological therapies of interest included psychological therapies (defined as biofeedback, progressive relaxation, and CBT). Outcomes of interest included pain intensity, functional status, short (...) improvement in anxiety compared with the wait-list control group. The results (change from baseline) for each of the individual groups are shown in Table 7. Mindfulness Training for Chronic Pain Management 9 Table 7: Within-group Results from Schmidt 2011 17 Outcome Wait-list (N = 59) PMR (N = 56) MBSR (N = 53) Mean ?BL P value Mean ?BL P value Mean ?BL P value QoL 0.19 0.11 0.13 0.34 0.39 0.017 FIQ 0.19 0.10 0.10 0.49 0.45 0.021 CES-D 0.15 0.18 0.04 0.79 0.36 0.012 STAI -0.05 0.63 0.12 0.17 0.41 0.003

2012 Canadian Agency for Drugs and Technologies in Health - Rapid Review

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>